Clinical Trial Update: High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease in Children [Phase 2]

View source ↗

Summary

Phase 2 trial update for high-dose oral 4-aminosalicylic acid (PASER) to control acute flares in children with Crohn's disease; study terminated with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• PASER (4-aminosalicylic acid)

Snippet

Sponsor: Jacobus Pharmaceutical | Conditions: Crohn's Disease | Phase 2 | Status: TERMINATED | Results posted: 2017-09-21